I do not disagree, however, I’m hoping they let this momentum build for a while and a private placement (no warrants) occurs closer to or above $10. We aren’t even back to uplist levels yet, so I think this has a lot more room to run yet and warrant money is coming in. This would obviously limit dilution and ultimately a raise like that should be accretive to our stock price, as funding to commercialization will be removed entirely, which is the major overhang on our stock at the moment.
Even better than the above would be a strategic partner coming in taking a 10-15% stake, once we are at higher levels, similar to what MDT and MZOR did recently.
“Opportunity of a lifetime”
News 
Market Data 
Discover 
